#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16592	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2214	746.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1480	1480	C	971	C	907	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30738	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3460	885.7	0	.	n	.	0	T695C	SNP	695	695	T	972	972	C	897	C,T	830,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30738	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3460	885.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1614	1614	A	1094	A,G	1021,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30738	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3460	885.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2248	2248	C	1024	C,T	945,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30738	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3460	885.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2322	2322	A	980	A	918	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30738	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3460	885.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2874	2874	C	991	C,T	918,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2380	folP	852	852	100.0	folP.l15.c4.ctg.1	1433	165.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1003	1005	AGC	261;257;257	A;G;C,T	243;240;238,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6046	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3420	176.2	1	SNP	p	S91F	0	.	.	271	273	TCC	523	525	TCC	203;206;209	T;C;C	189;189;194	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6046	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3420	176.2	1	SNP	p	D95N	0	.	.	283	285	GAC	535	537	GAC	214;212;210	G;A;C	194;189;190	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6046	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3420	176.2	1	SNP	p	D95G	0	.	.	283	285	GAC	535	537	GAC	214;212;210	G;A;C	194;189;190	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1932	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1298	148.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	455	457	ACC	241;238;237	A,G;C;C	215,1;219;217	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1932	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1298	148.3	0	.	p	.	0	R44H	NONSYN	130	132	CGC	470	472	CAC	239;239;240	C;A,G;C	217;214,1;219	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1932	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1298	148.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	653	655	CAC	245;241;243	C;A;C	222;215;221	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1932	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1298	148.3	1	SNP	p	G45D	0	.	.	133	135	GGC	473	475	GGC	239;242;244	G;G;C	220;220;224	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1024	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	986	103.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6336	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2923	216.1	1	SNP	p	D86N	0	.	.	256	258	GAC	561	563	GAC	255;255;256	G;A;C	242;237;244	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6336	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2923	216.1	1	SNP	p	S87I	0	.	.	259	261	AGT	564	566	AGT	256;257;257	A;G;T	244;240;241	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6336	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2923	216.1	1	SNP	p	S87R	0	.	.	259	261	AGT	564	566	AGT	256;257;257	A;G;T	244;240;241	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6336	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2923	216.1	1	SNP	p	S87W	0	.	.	259	261	AGT	564	566	AGT	256;257;257	A;G;T	244;240;241	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6336	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2923	216.1	1	SNP	p	S88P	0	.	.	262	264	TCC	567	569	TCC	259;260;257	T;C;C	242;245;242	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5046	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2721	184.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1627	1629	GGC	247;242;241	G;G;C	224;218;220	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4560	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	190.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1303	1305	GCA	244;248;249	G,A;C;A	225,2;231;232	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4560	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	190.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1306	1308	ATC	248;250;255	A;T,G,A;C	231;227,1,1;234	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4560	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	190.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1318	1320	GTG	257;256;257	G;T,A;G	237;231,1;236	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4560	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	190.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1318	1320	GTG	257;256;257	G;T,A;G	237;231,1;236	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4560	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	190.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1822	1824	ACC	240;243;239	A;C;C	216;221;218	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4560	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	190.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1876	1878	GCG	236;234;232	G;C;G	213;202;205	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4560	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	190.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1876	1878	GCG	236;234;232	G;C;G	213;202;205	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4560	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	190.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1999	2001	GGC	200;199;197	G;G;C	176;176;176	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4560	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	190.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2008	2010	GGC	195;188;188	G;G;C	169;161;168	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4560	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2386	190.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2026	2028	CCG	161;163;162	C,G;C,G;G,GGC	120,8;118,1;119,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6466	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3120	206.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2752	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1848	148.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	553	553	C	187	C	172	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3056	porB1b	1035	1035	95.73	porB1b.l6.c4.ctg.1	1624	187.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	494	496	GGA	291;294;293	G;G,T;A	263;269,1;270	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3056	porB1b	1035	1035	95.73	porB1b.l6.c4.ctg.1	1624	187.5	0	.	p	.	0	T87A	NONSYN	259	261	ACT	611	613	GCT	235;237;239	G;C;T	211;213;214	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3056	porB1b	1035	1035	95.73	porB1b.l6.c4.ctg.1	1624	187.5	0	.	p	.	0	F135L	NONSYN	403	405	TTT	755	757	CTT	204;208;208	C;T;T	183;188;189	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3056	porB1b	1035	1035	95.73	porB1b.l6.c4.ctg.1	1624	187.5	0	.	p	.	0	R143G	NONSYN	427	429	AGA	779	781	GGA	223;225;224	G,A;G;A	201,1;204;201	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3056	porB1b	1035	1035	95.73	porB1b.l6.c4.ctg.1	1624	187.5	0	.	p	.	0	D171G	NONSYN	511	513	GAT	863	865	GGT	247;249;252	G;G;T	228;229;231	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3056	porB1b	1035	1035	95.73	porB1b.l6.c4.ctg.1	1624	187.5	0	.	p	.	0	G189S	NONSYN	565	567	GGC	917	919	AGC	246;243;239	A;G;C	230;225;223	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3056	porB1b	1035	1035	95.73	porB1b.l6.c4.ctg.1	1624	187.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	983	983	T	221	T	211	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3056	porB1b	1035	1035	95.73	porB1b.l6.c4.ctg.1	1624	187.5	1	SNP	p	G120K	0	.	.	358	360	GGT	710	712	GGT	240;241;238	G;G;T	219;221;216	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3056	porB1b	1035	1035	95.73	porB1b.l6.c4.ctg.1	1624	187.5	1	SNP	p	A121D	0	.	.	361	363	GCC	713	715	GCC	235;235;235	G;C;C	215;214;218	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3056	porB1b	1035	1035	95.73	porB1b.l6.c4.ctg.1	1624	187.5	1	SNP	p	A121N	0	.	.	361	363	GCC	713	715	GCC	235;235;235	G;C;C	215;214;218	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11906	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4937	240.6	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2001	2003	AAT	310;309;306	A;A;T	276;277;273	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1298	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	963	133.7	1	SNP	p	V57M	1	.	.	169	171	ATG	465	467	ATG	293;293;289	A;T;G	268;267;264	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
